Opzelura uses and how it helps treat vitiligo
Vitiligo is a health condition that causes depigmented patches of the skin. A patient develops vitiligo when the immune system starts attacking melanocytes or the melanin-producing cells. While there is no cure for vitiligo, doctors generally recommend undergoing certain procedures for repigmentation of the skin to those who want to deal with the impact of the condition. Opzelura (ruxolitinib) is an FDA-approved topical repigmentation cream that can help treat vitiligo. Vitiligo progression Vitiligo is present in more than 1% of the world’s population. In most patients, the patches become apparent before the age of 25. But, the condition can occur in patients of all ages and genders. Moreover, people with autoimmune conditions like anemia, diabetes, rheumatoid arthritis, lupus, thyroid, psoriasis, and Addison’s disease are at a higher risk of developing vitiligo. The condition begins with a few patches or macules before starting to spread to the rest of the body. Hands, feet, forearms, and face are common parts of the body that first show the presence of vitiligo. The condition can also impact the patient’s mucous membranes, eyes, and inner ears. How Opzelura works For treating vitiligo, doctors can recommend using Opzelura—a prescription cream that helps restore the pigments in the macules and patches.
Read More